PHOX2B Analysis in Non-syndromic Neuroblastoma Cases Shows Novel Mutations and Genotype-phenotype Associations
Overview
Affiliations
Neuroblastoma (NB) is an embryonal tumor originating from neural crest cells and is one of the most common solid tumors of childhood. Recently, constitutional mutations in PHOX2B have been shown to confer an increased risk of NB. To date, mutations predisposing to neural crest tumors have been reported in 20 individuals from 16 families. These families included additional clinical features such as Hirschsprung (HSCR) disease or congenital central hypoventilation syndrome, either in the index case or relatives. The contribution of PHOX2B mutations to NB cases without additional features is unclear. To address this we sequenced PHOX2B in constitutional DNA from 86 individuals with non-syndromic NB (4 cases had a family history of NB). We identified two mutations, 600delC, a frameshift mutation in an individual with isolated, unifocal NB and G197D, a missense mutation that was present in a family with multiple individuals with NB but no evidence of autonomic dysfunction. These data demonstrate that PHOX2B mutations are a rare cause of non-syndromic NB. The mutations we identified are outside the domains typically mutated in PHOX2B syndromes. This provides further evidence that the underlying PHOX2B mutational mechanism influences tumor risk and suggests that the position of missense mutations may influence the resulting phenotype.
Heterozygosity mapping for human dominant trait variants.
Imai-Okazaki A, Li Y, Horpaopan S, Riazalhosseini Y, Garshasbi M, Mosse Y Hum Mutat. 2019; 40(7):996-1004.
PMID: 31018026 PMC: 6617796. DOI: 10.1002/humu.23765.
Associations between polymorphisms and neuroblastoma risk in Chinese children.
Hu C, Yang T, Pan J, Zhang J, Yang J, He J Biosci Rep. 2019; 39(4).
PMID: 30890582 PMC: 6449514. DOI: 10.1042/BSR20181582.
Pleiotropic effect of common variants in Hirschsprung disease and neuroblastoma.
Zhao J, Zhu Y, Xie X, Yao Y, Zhang J, Zhang R Aging (Albany NY). 2019; 11(4):1252-1261.
PMID: 30799307 PMC: 6402522. DOI: 10.18632/aging.101834.
Yang T, Zhang Z, Zhang J, Tan T, Yang J, Pan J BMC Cancer. 2018; 18(1):948.
PMID: 30285664 PMC: 6171233. DOI: 10.1186/s12885-018-4847-y.
Genetic susceptibility to neuroblastoma: current knowledge and future directions.
Ritenour L, Randall M, Bosse K, Diskin S Cell Tissue Res. 2018; 372(2):287-307.
PMID: 29589100 PMC: 6893873. DOI: 10.1007/s00441-018-2820-3.